Advances and innovations in haemophilia treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd.2018.70.pdf
Reference103 articles.
1. Lee, C. A., Berntorp, E. & Hoots, K. Textbook of Hemophilia. 2nd edn (Wiley-Blackwell, 2010).
2. Doolittle, R. F. Step-by-step evolution of vertebrate blood coagulation. Cold Spring Harb. Symp. Quant. Biol. 74, 35–40 (2009).
3. Srivastava, A. et al. Guidelines for the management of hemophilia. Haemophilia 19, e1–e47 (2013).
4. Hay, C. R. & DiMichele, D. M. The principal results of the International Immune Tolerance Study: a randomized dose comparison. Blood 119, 1335–1344 (2012). This paper summarizes the results of the largest, prospective study comparing two dose regimens of ITI in patients with high anti-drug antibody titres and puts these data into the context of historical studies and reports.
5. Dargaud, Y. et al. Achievements, challenges and unmet needs for haemophilia patients with inhibitors: report from a symposium in Paris, France on 20 November 2014. Haemophilia 22 (Suppl. 1), 1–24 (2016).
Cited by 90 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chitosan/β-glycerophosphate porous microsphere prepared by facile water-in-water emulsion as a topical hemostatic material;International Journal of Biological Macromolecules;2024-10
2. Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia;Annals of Hematology;2024-09-14
3. What is a cure through gene therapy? An analysis and evaluation of the use of “cure”;Medicine, Health Care and Philosophy;2024-08-22
4. Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review;Drugs in R&D;2024-08-20
5. Application of machine learning approaches for predicting hemophilia A severity;Journal of Thrombosis and Haemostasis;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3